**Core Concept:** Salmeterol is a long-acting beta2-agonist bronchodilator used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by binding to beta2-adrenergic receptors, which leads to smooth muscle relaxation and bronchodilation.

**Why the Correct Answer is Right:** Salmeterol is generally well-tolerated, but some side effects are known to occur. The correct answer is related to its cardiovascular system. Salmeterol can cause a decrease in heart rate, which may lead to bradycardia (slow heart rate) in some patients. This is because salmeterol is a selective beta2-agonist, which means it primarily stimulates beta2-adrenergic receptors without affecting alpha-adrenergic receptors. When the heart rate is decreased, it can lead to a feeling of lightheadedness, dizziness, or fainting in rare cases.

**Why Each Wrong Option is Incorrect:**
A. **Cardiac Arrest (Option A)**: This is not a direct side effect of salmeterol. Cardiac arrest is a life-threatening situation, which is not related to salmeterol's pharmacological action.

B. **Myocardial Infarction (Option B)**: Salmeterol does not cause myocardial infarction (heart attack). Although beta-agonists can increase heart rate, the overall cardiovascular risk is relatively low with salmeterol due to its selective beta2-agonist action.

C. **Atrial Fibrillation (Option C)**: This is not a direct side effect of salmeterol. Atrial fibrillation is a cardiac arrhythmia, which is not directly related to salmeterol's pharmacological action.

D. **Bradycardia (Option D)**: Salmeterol can indeed cause a decrease in heart rate, as mentioned earlier, making it a correct answer. However, it is a relatively rare side effect.

**Clinical Pearl:** While the risk of a severe cardiac event is low with salmeterol, it is essential for medical practitioners to be aware of potential side effects like bradycardia and monitor patients carefully after starting salmeterol therapy. Always consider the patient's medical history, especially for cardiovascular risk factors, and assess the patient's heart rate and blood pressure before and after salmeterol administration. This will help identify patients at higher risk for side effects and allow for appropriate management strategies to be implemented.

**Correct Answer:** Bradycardia (Option D)

---

**Explanation:**

Salmeterol, a long-acting beta2-agonist, is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by stimulating beta2-adrenergic receptors, which leads to bronchodilation and improved lung function. Although beta2-agonists are generally considered safe and well-tolerated, some side effects can occur, one of which is a decrease in heart rate (bradycardia). This is because salmeterol selectively activates beta2-adrenergic receptors, which can indirectly lead to a slower heart rate. However, this side effect is generally mild and self-limiting, typically resolving within